Scientists search for clues to stop Cancer's comeback after powerful treatment
NCT ID NCT05397132
Summary
This study aims to understand why some patients' blood cancers relapse or become resistant after CAR T therapy, a powerful cell-based treatment. Researchers will track 50 patients over time, analyzing their blood to see if specific immune system patterns can predict if and when the cancer might return. The goal is to gather knowledge that could help improve future treatments, not to test a new therapy on participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke University
RECRUITINGDurham, North Carolina, 27710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.